This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, The University of Versailles Saint-Quentin-En-Yvelines. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022-2026
Title: Alberto Epstein: Innovator in Neurogenic Detrusor Overactivity Treatment
Introduction
Alberto Epstein is a notable inventor based in Montigny-le-Bretonneux, France. He has made significant contributions to the field of medical technology, particularly in the treatment of neurogenic detrusor overactivity (NDO). His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.
Latest Patents
Epstein holds a patent for a method and pharmaceutical composition aimed at treating NDO. The patent, titled "Viral vectors for treating neurogenic detrusor overactivity," describes a viral expression vector that carries a transcription cassette. This cassette harbors transgenes that inhibit or silence neurotransmission or synaptic transmission of afferent neurons, providing a novel therapeutic strategy.
Career Highlights
Throughout his career, Alberto Epstein has worked with esteemed institutions such as the Université de Versailles-St Quentin-en-Yvelines and Assistance Publique-Hôpitaux de Paris. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Epstein has collaborated with notable colleagues, including François Giuliano and Olivier Le Coz. These partnerships have enriched his research and have been instrumental in advancing the understanding of neurogenic detrusor overactivity.
Conclusion
Alberto Epstein's innovative work in the treatment of neurogenic detrusor overactivity showcases his dedication to improving medical therapies. His contributions through patents and collaborations highlight the importance of innovation in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile